ARCHIMED to Take ZimVie Private in $730 Million Deal
October 20, 2025
ARCHIMED, via an affiliate and its MED Platform II fund, has agreed to acquire NASDAQ-listed ZimVie in a take-private transaction valued at approximately $730 million. ZimVie shareholders will receive $19.00 in cash per share, with the deal expected to close by the end of 2025 subject to customary approvals.
- Targets
- ZimVie
- Platforms
- MED Platform II
- Industry
- Medical Devices
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.